Tuesday, 26 March, 2024

Profluent Harnesses AI for Drug Discovery with Salesforce Research and Jeff Dean's Backing

Profluent, supported by Salesforce Research and Jeff Dean, leverages artificial intelligence (AI) to revolutionize drug discovery. The company's innovative approach integrates advanced AI algorithms to expedite the identification and development of new medicines. With backing from prominent figures like Jeff Dean and collaboration with Salesforce Research, Profluent aims to streamline the drug discovery process, potentially leading to breakthroughs in medical research and treatment development.